Singapore-based company upgrades its flagship supplement and secures halal certification ahead of a January 2026 launch.
EUDA Health Holdings Limited, a Singapore-based health technology company, will launch EUDA Helixé 2.0 in January 2026, marking a significant evolution of its flagship longevity supplement and a strategic step in the company’s broader global expansion plans.
The upgraded product introduces a stronger formulation, advanced delivery technology and premium packaging – alongside New Zealand halal certification, a move that opens doors to Muslim-majority markets across Southeast Asia, the Middle East and beyond. Vegetarian and vegan supplements are often halal by default, but certification still matters – because ethanol-based extraction, excipients, and manufacturing processes can all affect compliance.
For EUDA, the launch is not just about improving a supplement. It reflects a deliberate push to make longevity-focused healthcare more accessible, culturally inclusive and commercially scalable.
Helixé 2.0 is a reformulated blend designed to support everyday vitality rather than clinical treatment. The updated version contains 20% more New Zealand deer placenta powder, paired with a refined antioxidant profile that now includes Vitamin E, commonly associated with skin health and cellular protection.
Behind the scenes, EUDA has also upgraded how the supplement is made. Techniques such as freeze drying, nitrogen encapsulation, refined oil processing and nano emulsification are being used to improve stability, absorption and shelf life. While these processes may sound technical, the idea is simple: help the body absorb more of what it needs, more consistently.
EUDA is also introducing a new proprietary bottle design aimed at better protecting the product while strengthening its premium positioning on shelves.
One of the most notable changes is Helixé 2.0’s New Zealand halal certification, a decision that reflects both regulatory foresight and market opportunity.
With Muslim populations driving demand for wellness products that align with religious standards, EUDA is positioning Helixé 2.0 for wider acceptance in regions where halal compliance is essential. This includes parts of Southeast Asia and the Middle East, regions where preventive healthcare and longevity solutions are gaining traction alongside rising middle-class spending.
For investors, the certification signals a thoughtful approach to market entry rather than retrofitting compliance later.
Helixé was created by Professor Dr Lim Kah Meng, a molecular medicine scientist with over 80 global patents and a former senior researcher at Singapore’s A*STAR [1]. After years of working on stem cells and advanced regenerative therapies, he saw a gap that most people could not afford cutting-edge treatments.
Helixé emerged as a response, an attempt to translate high-level science into something practical, non-invasive, and accessible. Helixé 2.0 builds on that philosophy, focusing on daily wellness outcomes such as better sleep, improved recovery, clearer skin and sustained energy.
Manufactured in New Zealand, the supplement is positioned firmly in the premium wellness category.
The Helixé 2.0 launch comes as EUDA continues to expand its longevity strategy beyond supplements. Earlier, the company strengthened its pipeline with a stem cell therapy platform and opened its first longevity clinic in Shenzhen, China.
Together with its interests in immunotherapies and organoid technologies, EUDA is quietly building an end-to-end ecosystem that spans preventive care, regenerative medicine and consumer health. Helixé 2.0 sits at the front of that ecosystem, acting as an accessible entry point for consumers who may not yet be ready for clinical interventions.
As aging populations reshape healthcare priorities across Asia, EUDA’s strategy reflects that longevity is no longer just a clinical or luxury concept, but a part of daily life.
With Helixé 2.0, EUDA Health is making a clear statement. Longevity products can be science-backed without being intimidating, premium without being exclusive and global without ignoring cultural realities.
The year 2026 may mark more than a product upgrade. It could signal how longevity brands evolve to meet people where they are.
